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Abstract
Background: Some studies have implicated several possible metabolic linkages between osteoporosis and
vascular calcification, including estrogen deficiency, vitamin D excess, vitamin K deficiency and lipid oxidation
products. Nevertheless, it remains unclear whether osteoporosis and atherosclerosis are related to each other
or are independent processes, both related to aging. The aim of this cross-sectional study was to evaluate the
correlation between arterial thickening and bone status in a sample of apparently healthy Moroccan women.
Methods: Seventy-two postmenopausal women were studied. All patients were without secondary causes that
might affect bone density. Bone status was assessed by bone mineral density (BMD) in lumbar spine and all femoral
sites. Arterial wall thickening was assessed by intima-media thickness (IMT) in carotid artery (CA) and femoral
artery (FA). Prevalent plaques were categorized into four groups ranging from low echogenicity to high
echogenicity.
Results: The mean age was 59.2 ± 8.3 years. 84.7% had at least one plaque. By Spearman Rank correlation, CA
IMT was negatively correlated to Femoral total BMD (r = -0.33), Femoral neck BMD (r = -0.23), Ward triangle
BMD (r = -0.30) and Trochanter BMD (r = -0.28) while there was no association with lumbar BMD. In multiple
regression analysis, CA IMT emerged as an independent factor significantly associated with all femoral sites BMD
after adjusting of confounding factors. FA IMT failed to be significantly associated with both Femoral and Lumbar
BMD. No significant differences between echogenic, predominantly echogenic, predominantly echolucent and
echolucent plaques groups were found concerning lumbar BMD and all femoral sites BMD
Conclusion: Our results demonstrate a negative correlation between bone mineral density (BMD) qnd carotid
intima-media thickness (IMT) in postmenopausal women, independently of confounding factors. We suggest that
bone status should be evaluated in patients with vascular disease to assess whether preventive or therapeutic
intervention is necessarry.
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Background
Atherosclerosis and osteoporosis are two of the most com-
mon diseases that are correlated with the health of elderly
women. Both are often seen in the same individual. These
conditions progress silently until a fracture or myocardial
infarction occurs [1,2].
Previous studies have shown an association between oste-
oporosis and aortic [3-5] and carotid atherosclerosis [6],
cardiovascular mortality [7,8], stroke [7] and all-cause
mortality [9] in women and men. Both osteoporosis and
vascular calcification have largely been attributed to the
aging process. Recent studies have shown, however, that
arterial calcification is a highly regulated process, with
intriguing similarities to bone turnover [10,11] that may
be age-independent. The nature of the relationship
between osteoporosis and atherosclerosis remains
unclear. Some studies have implicated several metabolic
linkages between osteoporosis and vascular calcification.
These include estrogen deficiency [12], vitamin D excess
[13], vitamin K deficiency [14], and lipid oxidation prod-
ucts [15].
Measurement of the far-wall intima-media thickness
(IMT) of the common carotid artery (CA) and femoral
artery (FA) by high-resolution ultrasonography has been
established as a clinically useful index for identifying
early-stage general and local atherosclerosis in lower
extremities, because CA IMT is correlated strongly with the
presence of coronary artery disease [16-18] and FA IMT
with local atherosclerosis [19].
The aim of this cross-sectional study was to evaluate the
correlation between bone mineral density and artery IMT,
a measure of preclinical atherosclerosis, in a sample of
apparently healthy postmenopausal Moroccan women.
Methods
Subjects
The study involved 72 consecutive, ambulatory, Moroc-
can, postmenopausal women living in urban centre of
Morocco who were sent to our outpatient Bone Densit-
ometry Center. Recruitment was based on voluntary
enrolment. All subjects were referred to this center for
osteoporosis risk factors, including menopause. Oste-
oporosis was assessed by BMD and defined according to
the world Health Organization (WHO) (<2,5 standard
deviation of normal values for young people). Study
inclusion criteria were: (1) postmenopausal status (at
least 1 year of menopause). Exclusion criteria included
having a history of: (1) taking drugs known to influence
bone metabolism in the past 2 years, such as vitamin D,
calcium, corticosteroids, bisphosphonates and hormone
replacement therapy; (2) musculoskeletal, thyroid, par-
athyroid, adrenal, hepatic, or renal disease; (3) malig-
nancy,(4) hysterectomy; and (5) history of atherosclerotic
heart disease or stroke. The study was approved by ethical
committee of University-hospital Mohamed V Souissi and
all participants provided written consent.
Data collection and measurements
Each patient completed a questionnaire on sociodemo-
graphic parameters, atherosclerosis and osteoporosis risk
factors. The age of menopause, the time since menopause,
the personal history of cigarette smoking or alcohol intake
and the number of pregnancies were recorded.
For the evaluation of physical activity, we used the short
form of the International Physical Activity Questionnaire
(IPAQ) [20]. The items of IPAQ were structured to provide
separate scores on walking, moderate-intensity and vigor-
ous-intensity activity. Computation of the total score
requires summation of the duration (in minutes) and fre-
quency (days) of walking, moderate-intensity and vigor-
ous-intensity activities [21].
Anthropometric data
Weight and height were measured without clothes or
shoes at the time of bone densitometry measurements.
The Body mass index (BMI) was calculated as body
weight/height2 (kg/m2). The inter-assay CV of QC pools
was 3%.
Biochemical measurements
Morning fasting samples of venous blood were taken.
Serum total cholesterol (CT, enzymatic colorimetric
methods; reference value (RV) 1.4-2.4 g/l), serum high-
density lipoprotein (HDL, enzymatic colorimetric meth-
ods; RV,0.50-0.75 g/l), low-density lipoprotein (LDL,
enzymatic colorimetric methods; RV 0.65-1.75 g/l), trig-
lycerides (TG, enzymatic colorimetric methods; RV 0.22-
2.00 g/l) were measured. Serum Calcium (Ca, kinetic
colorimetric assay, RV, 84-97 mg/l); Phosphorus (P,
kinetic colorimetric assay, RV, 27-45 mg/l) and serum cre-
atinine(Cr, kinetic colorimetric assay, RV,5.1-9.5 mg/l)
were also measured. Osteocalcin (OC; ECLIA (electro-
chimiluminescence); RV, 15-46 ng/ml; Elecsys N-Mid
Osteocalcin), fasting urine cross-linked carboxy-terminal
telopeptide of type I collagen corrected by urinary creati-
nine (CTX, ECLIA (electrochimiluminescence); RV, 1.008
ng/ml; Elecsys bCross laps) were determined as bone
turnover markers. All theses measurements have been
made using Intégra 400 (Roche diagnostics; Mannheim,
Germany). Moreover, Serum 25 (OH)VitD (25-hydroxy-
vitamin D; chimiluminescence; (RV) 20-60 μg/ml; Liai-
son, Diasorin) and intact PTH (PTH; ECLIABMC Public Health 2009, 9:388 http://www.biomedcentral.com/1471-2458/9/388
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(electrochimiluminescence); RV, 15-65 pg/ml; Elecsys
Intact PTH) were assayed.
Bone mineral density (BMD)
Lumbar spine, trochanter, femoral neck and total hip
BMD were measured by dual-energy X-ray absorptiometry
with a Lunar prodigy densitometer. Daily quality control
was carried out by measurement of a Lunar phantom. At
the time of the study, phantom measurements showed
stable results. The phantom precision expressed as the
CV(%) was 0.08. Both T and Z scores were obtained. In
the T-score calculations, the manufacturer's ranges for
European population reference were used because of the
absence of a Moroccan data base.
Ultrasonography of the carotid artery (CA) and femoral 
artery (FA)
Ultrasonographic examination of the CA and FA was per-
formed in the supine position by the use of high-resolu-
tion B-mode ultrasonography performed with an
ultrasonography scanner (Xp10 128 ART-upgraded; Acu-
son, Mountain View, CA), as previously described [22]. To
avoid inter-observer variability, all measurements were
performed by the same examiner who was unaware of
subject characteristics. We recorded atherosclerotic
plaques from six sites of the carotid artery: The near and
far walls of both internal carotid arteries, the bifurcation
segment of the common carotid artery, and the common
carotid artery from the bifurcation segment to as far
downstream of the supraclavicular region as technically
possible; if more than one plaque was present at one of
the six sites, the thickest plaque was chosen for analysis.
Moreover ultrasound (US) imaging of the femoral arteries
was carried out at the level of the bifurcation on both the
right and left sides. Atherosclerotic plaque was defined as
localized protrusion of the internal part of the vessel wall
into the lumen. Plaque morphology in terms of echo-
genicity, defined as reflectance of the emitted ultrasound
signal, was assessed by the use of a visual analogue tech-
nique along a gray scale [22]. Plaques that appeared black
or almost black (like fluent blood inside the vessel) were
described as grade 1 (echolucent, low echogenic), whereas
plaques that appeared white or close to white (echogenic),
similar to the bright echo zone produced by the media-
adventitia interface in the far wall of the carotid artery,
were classified as grade 4. Grade 2 and grade 3 plaques
were interpolated between grades 1 and 4 along the black-
white scale, the grade 2 plaques consisting of more echo-
lucent than echogenic materials and the grade 3 plaques
vice versa. If one single plaque was present and the echo-
genicity inside this plaque was heterogeneous, the domi-
nant echogenicity determined the grading. When more
than one plaque was present, the echogenicity was graded
considering the overall plaque area [22]. The mean coeffi-
cient of variation [23] for the difference between IMT
measurement obtained in repeated examinations per-
formed by the same examiner was 3.2%.
Statistical analysis
Statistical analysis was performed with the Windows 13.0
version of SPSS software (SPSS Inc., Chicago, IL, USA).
Values are expressed mean ± S.D or percentages. Normal-
ity of the data was tested with a one-sample Kolmogorov
Smirnov test to indicate the appropriateness of parametric
testing. The correlation coefficients were calculated by
Pearson Rank correlation analyses due to normal distribu-
tion of various clinical variables. Multiple regression anal-
ysis was performed to assess independent association with
lumbar spine BMD and femoral BMD. For the relation
between plaque echogenicity and BMD, the comparison
between groups was made using analysis of covariance
(ANOVA). P-values of < 0.05 were considered as statisti-
cally significant.
Results
Clinical variables, intima-media thickness and bone 
density of patients
Characteristics of participants enrolled in this cross sec-
tional study are shown in table 1. The mean age and BMI
was 59.2 ± 8.3 years and 27.7 ± 4.5 kg/m2 respectively. Of
the 72 persons included in the study, 55.6% were oste-
oporotic and 84.7% had at least one plaque. The means of
triglycerides, serum total Cholesterol, high-density lipo-
protein and low-density lipoprotein were within normal
limits for reference laboratory. The means of CA and FA
IMT were to 0.8 ± 0.4 mm and 0.8 ± 0.3 mm respectively.
36.1% of Patients had femoral plaque and 59.7% had
carotid artery plaque. Plaques were distributed, according
to the echogenity, as follows: 31.9% Type I echolucent,
16.7% Type II predominantly echolucent, 9.7% type III
predominantly echogenic and 26.4% type IV echogenic.
The means of serum Calcium, Phosphorus, 25OH D3,
intact PTH, CTX and osteocalcin were within normal lim-
its for reference laboratory (results not shown in table 1).
There were no significant differences among the groups
osteoporotic versus no osteoporotic in age, age of meno-
pause, BMI, Physical activity score. Serum Calcium, Phos-
phorus, 25 OH D3, total Cholesterol, high-density
lipoprotein, low-density lipoprotein, Triglycerides, Intact
PTH, Osteocalcine, Cross laps and Creatinine were not
different and except for 25OH D3, were within normal
limits for reference laboratory. On the basis of vascular
ultrasound examination, the prevalence of artery plaques
for any of the sites examined was not significantly differ-
ent in patients with or without osteoporosis (p = 0.393).
No significant association was observed concerning the
plaque morphologic echography (p = 0.241). Results were
shown table 2.BMC Public Health 2009, 9:388 http://www.biomedcentral.com/1471-2458/9/388
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Correlations between CA IMT, FA IMT and clinical 
variables and BMD
Table 3 shows the summary of correlations of IMT with
clinical variables including BMD by Pearson Rank correla-
tion. Only Age was positively correlated with both CA and
FA IMT. CA IMT was negatively correlated to Trochanter
BMD, Femoral neck BMD, Ward triangle BMD and Femo-
ral total BMD (figure 1) while there was no association
with lumbar BMD. FA IMT failed to be significantly asso-
ciated with both Femoral and Lumbar BMD.
Multiple regression analysis of factors independently 
associated with BMD
In multiple regression analysis, CA IMT was an independ-
ent factor significantly associated with Trochanter BMD,
Ward triangle BMD, Femoral Neck BMD, femoral total
BMD but not lumbar spine BMD after adjusting of age,
age of menopause, serum LDL cholesterol, systolic blood
pressure and physical activity. Serum LDL cholesterol
emerged as an independent factor significantly associated
with femoral BMD (table 4).
BMD and plaques echogenicity
No significant differences between echogenic, predomi-
nantly echogenic, predominantly echolucent and echolu-
cent plaques groups were found concerning lumbar BMD
and all femoral sites BMD (data not shown).
Discussion
The most important finding in the present study is that CA
IMT emerged as an independent factor that is associated
significantly with Trochanter BMD, Femoral neck BMD,
Ward triangle BMD and Femoral total BMD, but not with
lumbar spine BMD. The association between trabecular or
cortical osteoporosis and calcification in different vascular
beds may vary, and should be considered when compar-
ing the reported findings. In many studies evaluating the
association between low bone mass and vascular calcifica-
tion, there was an independent association between BMD
at cortical sites, as represented by low hip BMD and vascu-
lar calcification [6,12,24]. However, studies measuring
BMD at predominantly trabecular sites, namely spinal
sites, failed to demonstrate this association [4,6,24,25]. In
Table 1: Characteristics of study participants
Number 72
Mean (SD)
Age (years) 59.2 ± 8.3
Years since menopause (years) 12.0 ± 8.2
Number of pregnancies 5.2 ± 3.4
Body mass index (kg/m2) 27.7 ± 4.5
Physical activity score (min/week) 3448 ± 1053
Systolic blood pressure (mmHg) 137 ± 17
Serum level
Triglyceride (g/l) 1.3 ± 0.7
Total Cholesterol (g/l) 2.1 ± 0.3
high-density lipoprotein (g/l) 0.5 ± 0.1
low-density lipoprotein (g/l) 1.2 ± 0.3
CA IMT (mm) 0.8 ± 0.4
FA IMT (mm) 0.8 ± 0.3
Lumbar spine BMD (g/cm2) 0.917 ± 0.172
Trochanter BMD (g/cm2) 0.669 ± 0.121
Femoral neck BMD (g/cm2) 0.823 ± 0.109
Ward triangle BMD (g/cm2) 0.645 ± 0.140
Femoral total BMD (g/cm2) 0.860 ± 0.111
Number (Percentage)
Current smoking 2 (2.8)
Osteoporosis 40 (55.6)
History of personal peripheral osteoporotic fractures 13 (18.1)
Number of individuals with plaque 61 (84.7)
Femoral Plaque 26 (36.1)
Carotid Plaque 43 (59.7)
Plaques echogenicity
No plaque 11 (15.3)
Type I echolucent 23 (31.9)
Type II predominantly echolucent 12 (16.7)
Type III predominantly echogenic 7 (9.7)
Type IV echogenic 19 (26.4)
CA: carotid artery, IMT: intima-media thickness, FA: Femoral arteryBMC Public Health 2009, 9:388 http://www.biomedcentral.com/1471-2458/9/388
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the past, this lack of association had been attributed to
methodological pitfalls related to Dual Energy X-ray
Absorptiometry (DXA) measurements. In fact, DXA meas-
urements of the spine are confounded by the presence of
calcified plaques in adjacent vessels and osteophytes [26].
Nevertheless, the lack of an association at trabecular sites
was confirmed by the Sinnot study [27] that used highly
sensitive and specific quantitative computerized tomogra-
phy (QCT) measures of exclusively trabecular bone of the
vertebrae. By contrast, previous studies have shown a neg-
ative association between lumbar BMD and IMT, but this
lack of association has also been described in hemodialy-
sis patients [28].
Our results indicate that FA IMT is not associated signifi-
cantly with BMD. Our data seem to be in contrast to the
earlier findings [5-8] that found a significant association
between FA IMT and bone status. It is also conceivable
that atherosclerotic distribution within the vascular tree
may vary considerably between vascular beds, and this
may explain some of the apparently conflicting findings
in the literature [24,29,30].
Another finding in the present study was that CA IMT is
associated significantly with all femoral site BMD inde-
pendently of age. Indeed, both osteoporosis and athero-
sclerosis increase with age, but the relationship between
them has remained unclear [31,32]. In some studies, the
apparent association between BMD and vascular calcifica-
tion disappeared after adjusting for age [25,31-33], while
in others, the association was independent of age
[3,14,33].
Table 2: Characteristics of study participants after splitting them in osteoporotic and no osteoporotic
Osteoporosis Non osteopotic patients P valuea
Number 40 32
Number of individuals with plaque
Femoral Plaque 19 (47.5) 16 (50.0) 0.393
Carotid Plaque 2 (5.0) 1 (3.1) 1.000
Plaques echogenicity
Type I echolucent 5 (12.5) 6 (22.2) 0.241
Type II predominantly echolucent 8 (20.0) 2 (06.2)
Type III predominantly echogenic 3 (7.5) 7 (21.8)
Type IV echogenic 3 (7.5) 2 (06.2)
Mean (SD)
Age (years) 59.1 ± 6.2 58.7 ± 6.5 0.797
Menopause age (yeras) 48.6 ± 5.5 48.0 ± 6.2 0.724
Number of pregnencies 6.0 ± 2.6 4.0 ± 2.0 0.193
Body mass index (kg/m2) 28.3 ± 4.0 26.3 ± 5.1 0.193
Physical activity score 2160 ± 1546 3690 ± 2134 0.200
Serum level
Triglyceride (g/l) 1.25 ± 0.41 0.97 ± 0.32 0.094
Total Cholesterol (g/l) 2.05 ± 0.30 2.06 ± 0.31 0.934
high-density lipoprotein (g/l) 0.55 ± 0.12 0.59 ± 0.19 0.572
low-density lipoprotein (g/l) 1.25 ± 0.24 1.27 ± 0.24 0.645
Calcium (mg/l) 97.33 ± 5.87 98.14 ± 5.15 0.533
Phosphorus (mg/l) 35.80 ± 4.60 37.20 ± 3.20 0.348
25 OH D3 (μg/l) 15.36 ± 7.46 16.01 ± 5.77 0.699
Table 3: Correlations of IMT in each segment with clinical 
characteristics and BMD
Clinical variables CA IMT FA IMT
Age (years) 0.227 * 0.309 *
Menopause age (years) -0.081 0.005
Body mass index (kg/m2) 0.087 0.042
Systolic blood pressure (mmHg) 0.038 -0.195
Triglyceride (g/l) -0.077 -0.015
High-density lipoprotein (g/l) 0.053 0.235
Low-density lipoprotein (g/l) 0.003 0.275
Physical activity score 0.024 -0.094
Lumbar spine BMD (g/cm2) -0.131 0.071
Femoral total BMD (g/cm2) -0.330 * -0.054
Femoral neck BMD (g/cm2) -0.237 * 0.041
Ward triangle BMD (g/cm2) -0.301 * -0.078
Trochanter BMD (g/cm2) -0.280 * -0.110
Values indicate bivariate correlation coefficients (Pearson's rho) 
obtained from 72 healthy Moroccan women. CA: carotid artery, IMT: 
intima-media thickness, FA: Femoral artery.
* p < 0.05BMC Public Health 2009, 9:388 http://www.biomedcentral.com/1471-2458/9/388
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The biological explanation for the possible relationship
between atherosclerosis and osteoporosis is unclear at
present, but several hypotheses have been proposed. Oxi-
dized lipids [15], impaired vitamin K status [14], homo-
cysteine, and high levels of osteoprotegerin [10,11] are
among the factors that may contribute to the association
between atherosclerosis and osteoporosis. Hamerman
[34] reviewed several possibilities, and pointed out that
inflammation is likely to be one of the processes that
influence atherogenesis and bone loss. Many of the
inflammatory mediators driving atherogenesis in the arte-
rial wall are known to be in the circulation as markers of
cardiovascular risk. These could gain access to bone,
where, together with local cytokines, they could enhance
the release of osteoblastic factors, that in turn promote
osteoclastogenesis.
Several researchers have suggested a role for hyperlipi-
demia and lipid oxidation [15] and inflammation [34]. In
vitro  studies have shown that oxidized lipids promote
osteoblastic differentiation of vascular cells and inhibit
such differentiation in bone cells [35]. One possible
mechanism by which this may occur is through accumu-
lation of oxidized lipids in tissue so as to mimic chronic
infection, thereby stimulating an immune response that
promotes the hardening of soft tissue (to wall off infec-
tious agents) and the softening of hard tissue (to dissolve
a substrate for growth of infectious agents). In our study,
serum LDL cholesterol emerged as an independent factor
that is associated significantly with femoral BMD, after
adjusting for age and CA IMT.
Although several studies have shown that increasing BMD
is related to a decreasing prevalence of echogenic plaque
[36,37], our results found no significant differences
between the four groups according to the plaque echo-
genicity in lumbar and femoral BMD.
There are several potential limitations to this cross-sec-
tional study. First, the subjects were not recruited from the
community at large, but were selected from patients who
underwent bone density determinations. This selection
bias may explain the relatively high prevalence of oste-
oporosis in the subjects studied. In fact, we have already
shown that 31 to 39% of post-menopausal women had
osteoporosis [38-40]. Another bias is related to the classi-
fication of plaques. Despite the fact that the reproducibil-
ity of plaque echogenicity was good, some
misclassification may have occurred. Lastly, we have no
direct histopathological demonstration that increased
IMT is due to atherosclerosis. The arterial thickening
might have been due to another, non-atherosclerotic arte-
riopathy. However, IMT measurements are still useful in
that IMT is strongly correlated with the presence of coro-
nary artery diseases.
Conclusion
In brief, our results showed that decreased BMD is corre-
lated with increased CA IMT in postmenopausal women,
independently of confounding factors. We suggest that
bone status should be evaluated in patients with vascular
disease to assess whether preventive or therapeutic inter-
vention is necessary.
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